SCHEMBL7862814

SCHEMBL7862814

CC(C)(C)OO[P](=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6242458 0.75 TSHR (0.44)
SCHEMBL6780503 0.69
SCHEMBL21848148 0.69 TSHR (0.37)
SCHEMBL8321446 0.65
SCHEMBL18968461 0.65
Boric Acid SCHEMBL28380257 0.65 TSHR (0.39)
SCHEMBL28131506 0.63 TSHR (0.44)
Methyl Alcohol SCHEMBL8043491 0.61 TSHR (0.80)
Hydrogen Peroxide SCHEMBL2635895 0.61 TSHR (0.80)
SCHEMBL10654485 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115776891-A STAT degradants and uses thereof 凯麦拉医疗公司 2023-03-10 CN disclosed
EP-1093453-A1 NAALADASE INHIBITORS USEFUL AS PHARMACEUTICAL COMPOUNDS AND COMPOSITIONS GUILFORD PHARMACEUTICALS INC. (US) 2001-04-25 EP disclosed
WO-2000001668-A2 NAALADASE INHIBITORS USEFUL AS PHARMACEUTICAL COMPOUNDS AND COMPOSITIONS GUILFORD PHARMACEUTICALS INC. (US) 2000-01-13 WO disclosed